Literature DB >> 27209327

Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review.

Khyati Brahmbhatt1, Donald M Hilty2, Mina Hah3, Jaesu Han4, Kathy Angkustsiri5, Julie B Schweitzer6.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder with a worldwide prevalence of about 5% in school-age children. This review is intended to assist primary care providers (PCPs) in diagnosing and treating ADHD in adolescents. PubMed, PsychInfo, and Science Citation Index databases were searched from March 1990 to 2015 with the keywords: ADHD, primary care/pediatrics, and children/adolescents. Abstracts addressing diagnosis and/or treatment with 105 citations were identified including supplementary treatment guidelines/books. Adolescent ADHD presents with significant disturbances in attention, academic performance, and family relationships with unique issues associated with this developmental period. Diagnostic challenges include the variable symptom presentation during adolescence, complex differential diagnosis, and limited training and time for PCPs to conduct thorough evaluations. The evidence base for treatments in adolescence in comparison to those in children or adults with ADHD is relatively weak. Providers should be cognizant of prevention, early identification, and treatment of conditions associated with ADHD that emerge during adolescence such as substance use disorders. Adolescent ADHD management for the PCP is complex, requires further research, and perhaps new primary care psychiatric models, to assist in determining the optimal care for patients at this critical period.
Copyright © 2016 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Adolescent; Attention deficit hyperactivity disorder; Evaluation; Primary care; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27209327      PMCID: PMC5576000          DOI: 10.1016/j.jadohealth.2016.03.025

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  99 in total

1.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

2.  Beyond rising rates: personalized medicine and public health approaches to the diagnosis and treatment of attention-deficit/hyperactivity disorder.

Authors:  John T Walkup; Lauren Stossel; Rebecca Rendleman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-22       Impact factor: 8.829

3.  Special issue on the teenage brain: Sensitivity to social evaluation.

Authors:  Leah H Somerville
Journal:  Curr Dir Psychol Sci       Date:  2013-04-01

4.  Reduced acute recovery from alcohol impairment in adults with ADHD.

Authors:  Walter Roberts; Richard Milich; Mark T Fillmore
Journal:  Psychopharmacology (Berl)       Date:  2013-02-21       Impact factor: 4.530

Review 5.  Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety.

Authors:  Charmaine K Higa-McMillan; Sarah E Francis; Leslie Rith-Najarian; Bruce F Chorpita
Journal:  J Clin Child Adolesc Psychol       Date:  2015-06-18

6.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

Review 7.  Safety of medicines used for ADHD in children: a review of published prospective clinical trials.

Authors:  Antonio Clavenna; Maurizio Bonati
Journal:  Arch Dis Child       Date:  2014-04-19       Impact factor: 3.791

Review 8.  Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Authors:  Himanshu P Upadhyaya
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

9.  Fading memories: retrospective recall inaccuracies in ADHD.

Authors:  Carlin J Miller; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  J Atten Disord       Date:  2009-09-30       Impact factor: 3.256

Review 10.  Diagnosis and treatment of ADHD in adults in primary care.

Authors:  Brendan Montano
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

View more
  5 in total

1.  Mother-Adolescent Discrepancies in Ratings of Adolescents' Adjustment: Associations with Maternal Mental Health and Family Factors.

Authors:  Marya Rana; Erin Delker; Patricia East; Estela Blanco; Raquel Burrows; Betsy Lozoff; Sheila Gahagan
Journal:  J Dev Behav Pediatr       Date:  2021-04-01       Impact factor: 2.988

2.  Accurate Identification of ADHD among Adults Using Real-Time Activity Data.

Authors:  Amandeep Kaur; Karanjeet Singh Kahlon
Journal:  Brain Sci       Date:  2022-06-26

3.  A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD.

Authors:  Azmi Nasser; Tesfaye Liranso; Toyin Adewole; Nicholas Fry; Joseph T Hull; Fatima Chowdhry; Gregory D Busse; Zare Melyan; Andrew J Cutler; Robert L Findling; Stefan Schwabe
Journal:  Psychopharmacol Bull       Date:  2021-03-16

Review 4.  Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth.

Authors:  Maria Demma I Cabral; Stephanie Liu; Neelkamal Soares
Journal:  Transl Pediatr       Date:  2020-02

5.  A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Authors:  Azmi Nasser; Tesfaye Liranso; Toyin Adewole; Nicholas Fry; Joseph T Hull; Gregory D Busse; Fatima Chowdhry; Andrew J Cutler; Nandita Joshi Jones; Robert L Findling; Stefan Schwabe
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.